Correlation Between Samsung Life and PanGen Biotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Samsung Life and PanGen Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Samsung Life and PanGen Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Samsung Life Insurance and PanGen Biotech, you can compare the effects of market volatilities on Samsung Life and PanGen Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Samsung Life with a short position of PanGen Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Samsung Life and PanGen Biotech.

Diversification Opportunities for Samsung Life and PanGen Biotech

0.61
  Correlation Coefficient

Poor diversification

The 3 months correlation between Samsung and PanGen is 0.61. Overlapping area represents the amount of risk that can be diversified away by holding Samsung Life Insurance and PanGen Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on PanGen Biotech and Samsung Life is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Samsung Life Insurance are associated (or correlated) with PanGen Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of PanGen Biotech has no effect on the direction of Samsung Life i.e., Samsung Life and PanGen Biotech go up and down completely randomly.

Pair Corralation between Samsung Life and PanGen Biotech

Assuming the 90 days trading horizon Samsung Life Insurance is expected to generate 0.76 times more return on investment than PanGen Biotech. However, Samsung Life Insurance is 1.31 times less risky than PanGen Biotech. It trades about 0.09 of its potential returns per unit of risk. PanGen Biotech is currently generating about -0.11 per unit of risk. If you would invest  9,860,000  in Samsung Life Insurance on September 14, 2024 and sell it today you would earn a total of  530,000  from holding Samsung Life Insurance or generate 5.38% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Samsung Life Insurance  vs.  PanGen Biotech

 Performance 
       Timeline  
Samsung Life Insurance 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Samsung Life Insurance are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, Samsung Life is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
PanGen Biotech 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in PanGen Biotech are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, PanGen Biotech sustained solid returns over the last few months and may actually be approaching a breakup point.

Samsung Life and PanGen Biotech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Samsung Life and PanGen Biotech

The main advantage of trading using opposite Samsung Life and PanGen Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Samsung Life position performs unexpectedly, PanGen Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PanGen Biotech will offset losses from the drop in PanGen Biotech's long position.
The idea behind Samsung Life Insurance and PanGen Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.

Other Complementary Tools

Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges